HROW Q2 2017 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$7M+39.7% YoY

Gross Profit

$4M52.0% margin

Operating Income

-$3M-44.0% margin

Net Income

$1M21.6% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+12.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$667,000

Balance Sheet

Total Assets

$28M

Total Liabilities

$20M

Stockholders' Equity

$8M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$5M	+39.7%
Gross Profit	$4M	$3M	+30.5%
Operating Income	-$3M	-$4M	+24.7%
Net Income	$1M	-$5M	+132.0%